Monoclonal antibodies improve therapy of relapsing multiple sclerosis. Molecular basis and clinical results of anti-VLA4 (natalizumab) therapy. - Gold,R.; Hartung,H.P.; Hohlfeld,R. (Dtsch Med Wochenschr, 2006)